FDA greenlights Cobenfy, marking first new schizophrenia drug in decadesSeptember 29, 2024 The FDA has approved Cobenfy, the first new schizophrenia medication in over 30 years, offering a novel treatment approach for managing symptoms like hallucinations and delusions.
